LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions

PHASE4RecruitingINTERVENTIONAL
Enrollment

960

Participants

Timeline

Start Date

May 10, 2023

Primary Completion Date

May 30, 2027

Study Completion Date

May 30, 2027

Conditions
AnginaStable Ischemic Heart Disease
Interventions
OTHER

Clinician Discretion

Clinician discretion as to which BB or CCB will be used if the participant has a heart rate and blood pressure within normal limits.

DRUG

Beta blocker

Selection of the specific BB and initial starting dose will be determined by the treating clinician.

DRUG

Calcium channel blocker

Selection of the specific CCB and initial starting dose will be determined by the treating clinician.

Trial Locations (9)

10029

RECRUITING

Mt. Sinai Health System, New York

10469

RECRUITING

Nirvana Integrative Medicine, New York

22033

RECRUITING

Inova Health Care Services, Fairfax

27710

RECRUITING

Duke University, School of Medicine, Durham

30060

RECRUITING

Wellstar Research Institute, Marietta

60612

RECRUITING

Cook County Health, Chicago

06520

RECRUITING

Yale School of Medicine, New Haven

02115

RECRUITING

Brigham and Women's Hospital, Boston

10037-1802

NOT_YET_RECRUITING

NYC Health and Hospitals, Harlem Hospital, New York

All Listed Sponsors
lead

Yale University

OTHER